The Recovery trial is a single-blinded, randomized trial that compared the ClosureFAST catheter with endovenous laser ablation in 62 limbs.
Dr. Proebstle of Heidelberg, Germany, said: “Our study found the ratio of efficacy to side effects of the VNUS ClosureFAST catheter to be superior to any previous endovenous ablation device. In 223 cases where the ClosureFAST device was used, 96.7% of the veins remained sealed after one year using Kaplan-Meier analysis.”